Home/Filings/4/0001595585-21-000024
4//SEC Filing

Otto Dawn Parsell 4

Accession 0001595585-21-000024

CIK 0001595585other

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 5:18 PM ET

Size

5.5 KB

Accession

0001595585-21-000024

Insider Transaction Report

Form 4
Period: 2021-01-17
Otto Dawn Parsell
Sr VP, Clinical Development
Transactions
  • Award

    Common Stock

    2021-01-17+186,000186,000 total
    Exercise: $7.03Exp: 2031-01-16Common Stock (186,000 underlying)
Footnotes (1)
  • [F1]The option to purchase common stock will vest as follows: (a) 25% of the shares subject to the options shall vest on January 17, 2022 and (b) the remaining 75% vest in 36 equal monthly installments thereafter, subject to reporting person's continuous service as of each vesting date.

Issuer

Tricida, Inc.

CIK 0001595585

Entity typeother

Related Parties

1
  • filerCIK 0001748808

Filing Metadata

Form type
4
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 5:18 PM ET
Size
5.5 KB